Friday, August 31, 2018

Outset Medical Takes $132M For Dialysis Treatment

San Jose-based Outset Medical, which develops technology aimed at reducing the cost and complexity of dialysis, has raised $132M in a Series D funding, the company said this week. The funding was led by Mubadala Investment Company, and also included Baxter Ventures, Fidelity Management and Research Company, Partner Fund Management LP, Perceptive Advisors, funds advised by T. Rowe Price Associates Inc., and Warburg Pincus. Outset Medical said the funding goes towards increasing its production capabilities, and commercial expansion. Leslie Trigg is CEO of Outset Medical.